BridgeMD
New treatment option for Fibromyalgia
Official title Intermittent Theta Burst Stimulation in Fibromyalgia Syndrome
ClinicalTrials.gov ID: NCT06746922
What this study is testing
- What it's testing
- Research on repetitive transcranial magnetic stimulation therapy in fibromyalgia syndrome (FMS) is increasing rapidly. High-frequency rTMS administration to FMS patients is reported to restore intracortical facilitation and provide successful pain relief.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Being between the ages of 18-65
- Being diagnosed with fibromyalgia syndrome (according to 2016 criteria)
- Average pain intensity of NRS ≥ 4/10
- Fibromyalgia treatment was stable for the last 3 months and no treatment change was planned during the study
You likely can't join if
- Having a clinical condition that would constitute a contraindication for TMS (metallic implant, cardiac pacing, pregnancy, epilepsy, head trauma...
- Presence of malignancy
- Systemic rheumatologic diseases
- Major orthopedic problems limiting activities of daily living (gait disturbance or fracture sequelae limiting joint mobility, prostheses...
- Serious neurological diseases (increased intracranial pressure, presence of space-occupying lesions in the brain, history of epilepsy, presence of...
- Alcohol or drug addiction
See the full eligibility criteria
- Being between the ages of 18-65
- Being diagnosed with fibromyalgia syndrome (according to 2016 criteria)
- Average pain intensity of NRS ≥ 4/10
- Fibromyalgia treatment was stable for the last 3 months and no treatment change was planned during the study
- Having a clinical condition that would constitute a contraindication for TMS (metallic implant, cardiac pacing, pregnancy, epilepsy, head trauma, history of cranial operation...)
- Presence of malignancy
- Systemic rheumatologic diseases
- Major orthopedic problems limiting activities of daily living (gait disturbance or fracture sequelae limiting joint mobility, prostheses, nerve-tendon injuries)
- Serious neurological diseases (increased intracranial pressure, presence of space-occupying lesions in the brain, history of epilepsy, presence of cerebral aneurysm, Parkinson's disease, Huntington's chorea, multiple...
- Alcohol or drug addiction
- History of major depression/personality disorder or psychosis
- Having received TMS treatment before
- Taking benzodiazepine, gabapentin/pregabalin or anticonvulsant medications that have the potential to interfere with intermittent theta burst stimulation treatment or have taken them within the last 4 weeks
- Pregnant or planning pregnancy or breastfeeding
The study team makes the final eligibility decision.
Where it's taking place
- Izmir, Karabaglar, Turkey (Türkiye)
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Izmir, Karabaglar, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.